---
title: "Mystery and Insurability: Unraveling the Challenge of Multiple Sclerosis"
date: 2017-03-24T01:02:05+0000
author: matt
draft: True
---
It may become even more challenging to underwrite applicants with Multiple Sclerosis (MS), and that is positive news for patients. Medical advances are outpacing mortality data so swiftly that, within the decade, it could be possible for the majority of applicants to be prescribed medications for which there are currently no long-term experience studies.

[ http://www.rgare.com/knowledge-center ]( http://www.rgare.com/knowledge-center/media/articles/mystery-and-insurability )
